BrightMEM allograft results in epithelialization in nonhealing corneal diseases

KIAWAH ISLAND, S.C. — An anterior keratoplasty technique using a decellularized Descemet’s membrane allograft yielded robust corneal epithelialization in patients with nonhealing ocular surface diseases, according to new research.BrightMEM from Brightstar Therapeutics is a corneal allograft created from donated human cornea tissue that is designed to be transplanted onto the ocular